Akynzeo

(netupitant / palonosetron)
20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection [Akynzeo]fosnetupitant 235 MG / palonosetron 0.25 MG Injection [Akynzeo]
View 1 more
NO BLACK BOX WARNING

Dosage & administration

AKYNZEO capsules

AKYNZEO for injection and AKYNZEO injection


eficacy, safety & testing

Akynzeo clinical details

drug label

Akynzeo prescribing information

Need to report an Akynzeo issue?

ONLINE FORM
Report adverse event
Learn More

samples

Request Akynzeo samples

NOT PROVIDED BY BRAND
Request Samples
Learn More

prior authorization

Akynzeo Prior authorization resources

NOT PROVIDED BY BRAND
Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request

NOT PROVIDED BY BRAND
Coverage Authorization Appeals
Learn More

Benefits investigation

NOT PROVIDED BY BRAND
Benefits investigation resources
Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRAND
Reimbursement help (FRM) resources
Learn More

financial assistance

Akynzeo Financial assistance options

Co-pay savings program

commercial only

NOT PROVIDED BY BRAND
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Learn More

patient education

Akynzeo Patient education

Getting started on Akynzeo

Instructions For Use - Prevention of Nausea & Vomitting during Chemotherapy
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient toolkit

NOT PROVIDED BY BRAND
Not Provided By Brand
Learn More

people also ask

Akynzeo FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.